Aerovate Therapeutics, Inc.

NASDAQ
AVTE
Stock
Yield per half year: +1.52%
Dividend yield: 2.56%
Sector: Healthcare

Share chart Aerovate Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 2021-06-30
ISIN US0080641071
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 2.56
Дивиденд ао 2.4
Сайт link
Цена ао 93.8
Change price per day: -97.14% (93.8)
Change price per week: -97.14% (93.8)
Change price per month: -97.14% (93.8)
Change price per 3 month: -96.85% (85.05)
Change price per half year: +1.52% (2.64)
Change price per year: -84.24% (17)
Change price per 3 year: -78.47% (12.45)
Change price per year to date: -97.09% (92.05)
All parameters

Grade

Underestimation
Title Value Grade
P/S 0 0
P/BV 5.58 2
P/E 0 0
EV/EBITDA -7.23 0
Total: 2.25
Efficiency
Title Value Grade
ROA, % -59.27 0
ROE, % -69 0
Total: 0
Dividends
Title Value Grade
Div yield, % 2.56 6.4
DSI 1 10
Total: 4.85
Debt
Title Value Grade
Debt/EBITDA -0.0083 10
Total: 10
Growth impulse
Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 2364.03 10
Yield EPS, % 104.86 10
Total: 8
More

Main owners

Institutions Volume Share, %
RA Capital Management, L.P. 8 263 982 29.66
Sofinnova Investments, Inc. 3 758 686 13.49
Tcg Crossover Management, Llc 2 201 274 7.9
Atlas Venture Life Science Advisors, LLC 2 039 249 7.32
Baker Brothers Advisors, LLC 1 680 517 6.03
Cormorant Asset Management, LP 1 211 696 4.35
Frazier Life Sciences Management, L.P. 1 204 867 4.32
Driehaus Capital Management, LLC 1 058 209 3.8
Great Point Partners LLC 1 037 690 3.72
Orbimed Advisors LLC. 756 930 2.72

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Mr. Timothy P. Noyes M.B.A. CEO & Director 936.9k 1962 (63 years)
Mr. George A. Eldridge CFO & Treasurer 658.6k 1963 (62 years)
Dr. Marinus Verwijs Ph.D. Chief Technical Officer 439.88k 1976 (49 years)
Dr. Benjamin T. Dake Ph.D. Founder, President, COO & Secretary 435.5k 1976 (49 years)
Dr. Ralph W. Niven M.B.A., M.R, Ph.D., Pharm.S Chief Scientific Officer 372.33k 1960 (65 years)
Mr. Hunter Gillies M.D. Chief Medical Officer 512.74k 1966 (59 years)
Mr. Timothy J. Pigot Chief Commercial Officer 584.6k 1971 (54 years)
Ms. Donna Dea Head of Regulatory Affairs N/A
Ms. Susan Fischer Executive Vice President of Development Operations N/A
Mr. Stephen K. Yu Senior Vice President of Quality N/A

About company

Address: United States, Waltham. MA, 930 Winter Street - Open in google maps, Open in yandex maps
Website: https://aerovatetx.com